Hepatitis E Virus (HEV) Antibody, IgG
Use
Qualitative detection of IgG antibodies to Hepatitis E virus (HEV), which typically indicates past exposure or remote infection. HEV is uncommon in the U.S. but should be considered in patients with symptoms of acute viral hepatitis who test negative for other common hepatitis viruses or who have traveled to endemic regions.
Special Instructions
Not provided.
Limitations
Interpretation of IgG indicates prior exposure and does not distinguish between remote or resolved infection; cross-reactivity with other viral antigens is possible; not intended to diagnose acute HEV infection — IgM testing may be required to identify recent or active infection.
Methodology
Immunoassay (ELISA)
Biomarkers
Hepatitis E Virus IgG antibody
Protein
LOINC Codes
- 14211-7 - HEV IgG Ser Ql
Result Turnaround Time
2-5 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.3 mL
Container
Serum separator tube (also acceptable red top, lavender EDTA, pink K₂EDTA)
Collection Instructions
Separate from cells ASAP or within 2 hours of collection
Storage Instructions
Refrigerated
Causes for Rejection
Specimens with particulate material (ARUP)
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 2 weeks (ARUP); 14 days (Warde) |
| Frozen | Indefinitely (ARUP); 30 days (Warde) |
Other tests from different labs that may be relevant